Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural approach for COX-2 inhibition.

C Michaux1, C Charlier

  • 1Laboratory of Molecular and Structural Chemistry, Facultés Universitaires N.-D. de la Paix, 61 rue de Bruxelles, B-5000 Namur, Belgium. catherine.michaux@fundp.ac.be

Mini Reviews in Medicinal Chemistry
|July 29, 2004
PubMed
Summary

Selective cyclooxygenase-2 (COX-2) inhibitors offer potent anti-inflammatory drugs with fewer side effects. This review details drug design strategies for understanding their binding and selectivity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel reusable transcriptome-wide association study workflow used to map key genes linked to important cattle traits.

Genomics·2026
Same author

[Pneumonia and pregnancy].

Revue des maladies respiratoires·2025
Same author

Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets.

International journal of pharmaceutics·2024
Same author

Leprosy combined with vitiligo skin lesions.

La Revue de medecine interne·2023
Same author

Shotgun metagenomic screening to improve the retrospective diagnosis of undocumented intrauterine infections on embedded placenta samples: Lessons from a brucellosis case.

Infectious diseases now·2023
Same author

Modulation of the functional interfaces between retroviral intasomes and the human nucleosome.

mBio·2023

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Drug Design

Background:

  • Selective cyclooxygenase-2 (COX-2) inhibitors represent a novel therapeutic strategy.
  • Developing potent anti-inflammatory drugs with reduced adverse effects is a key goal in medicinal chemistry.
  • Existing literature reports several families of COX-2 inhibitors.

Purpose of the Study:

  • To review the drug design processes employed in the development of selective COX-2 inhibitors.
  • To elucidate the binding modes of these inhibitors.
  • To understand the molecular basis of their selectivity.

Main Methods:

  • Literature review of drug design strategies for COX-2 inhibitors.
  • Analysis of structure-activity relationships (SAR) and molecular modeling studies.

Related Experiment Videos

  • Examination of crystallographic and biochemical data.

    • Main Results:

    • Detailed description of various drug design approaches for selective COX-2 inhibitors.
    • Insights into the specific interactions governing the binding of inhibitors to the COX-2 active site.
    • Identification of key structural features responsible for COX-2 selectivity over COX-1.

    Conclusions:

    • Drug design has successfully yielded potent and selective COX-2 inhibitors.
    • Understanding binding modes and selectivity origins is crucial for optimizing anti-inflammatory drug development.
    • Selective COX-2 inhibitors hold significant promise for safer anti-inflammatory therapies.